source
- Labcorp reports Q2 sales of $3.73 billion, lifts full-year revenue outlook despite missing consensusLabcorp announced second‑quarter revenue of $3.73 billion, up from $3.53 billion a year earlier, driven by strong performance across its core businesses. The Diagnostics division grew 5.5% to $2.9…
- Boston Scientific lowers full-year revenue outlook as restructuring plan targets slowing growthBoston Scientific announced on July 29 that it is cutting its 2026 full-year organic revenue growth forecast to 5-6%, down from the prior 6.5-8% range. The revision follows a second consecutive qu…